Beruflich Dokumente
Kultur Dokumente
Risk
Culture on Risk
Risk Hazard
Communication
Graph Cause
Implementation of Residual Verification
Training Risk Control Risk Of Post
Of Measures Effectiveness Production
Personnel Monitoring
QCI CQE
Primer
Risk ranking of complex systems typically These factors are combined into a single
involves evaluation of diverse quantitative and relative risk score that can then be used for
qualitative factors for each risk. ranking risks.
The tool involves breaking down a basic risk “Filters,” in the form of weighting factors or cut-
question into as many components as needed offs for risk scores, can be used to scale or fit
to capture factors involved in the risk. the risk ranking to management or policy
objectives.
Risk Ranking and Filtering Risk Ranking and Filtering (FDA Q9)
Risk
Page 1 or 1
Model Year/Vehicle(s): Design Responsibility P rep a re d b y: L e e D aw s o n
F ME A D ate (O rig .):
Core Team: Key Date:
Assessment
Potential Potential S L Cause(s)/ C Design Design E R. Recommended & Target
Failure Effect(s) of E A Mechanism(s) C T P. S O D R.
Controls Controls Action(s) Completion Actions
Mode Failure V S U E N.
Date
E C E P.
Function S Of Failure R Prevention Detection C Taken V C T N.
Risk Evaluation
10
Cause Failure Effect
Tolerability of Risk 9 Mode
• Risk Acceptability Decision
Cost-Benefit Analysis 8
Socio/Ethical Analysis 7
Risk Ishikawa 6
5
Management
4 IV. Minor
Risk Control 3 III. Marginal
FMECA 2
• Options analysis FMECA II. Critical
1
• Implementation HACCP I. Catastrophic
0
• Residual Risk Evaluation HAZOP A. Very High B. High C. Moderate D. Low E. Remote
• Overall Risk Acceptance PAT Probability of Occurance
Criticality Matrix
Post-production Information
• Post-production experience Six Sigma DOE
• Systemic Procedures SPC
• Identification of new Hazards CAPA Multivariate Analysis
• Change Control & Feedback Loop Complaint Mgmt.
SPC
Cost-Benefit Analysis – choosing options for Risk control might focus on the following
the optimal level of control. questions:
– Is the risk above an acceptable level?
– What can be done to reduce or eliminate risks?
– What is the appropriate balance among benefits,
risks and resources?
– Are new risks introduced as a result of the identified
risks being controlled?
Risk Mgmt as part of Integrated Quality Mgmt Risk Mgmt as part of Integrated Quality Mgmt
(FDA Q9) (FDA Q9)
Quality defects Auditing/Inspection
– To provide the basis for identifying, evaluating, and – To define the frequency and scope of audits, both
communicating the potential quality impact of a internal and external. Factors such as:
suspected quality defect, complaint, trend, deviation, • Existing legal requirements
investigation, out of specification, etc. • Compliance status and history of the company or facility
– To facilitate risk communications and determine • Robustness of a company’s quality risk management
appropriate action to address significant product • Complexity of the site
defects, in conjunction with regulatory authorities • Complexity of the manufacturing process
(e.g., recall). • Complexity of the product and its therapeutic significance
• Number and significance of quality defects (e.g., recall)
• Results of previous audits/inspections
• Major changes of building, equipment, processes, key
personnel
• Experience with manufacturing of a product
• Test results from laboratories
Copyright © 2017 Mark Lindsey 87 Copyright © 2017 Mark Lindsey 88
Risk Mgmt as part of Integrated Quality Mgmt Risk Mgmt as part of Integrated Quality Mgmt
(FDA Q9) (FDA Q9)
Change management/Change control
Periodic review
– To manage changes based on knowledge and
– To select, evaluate, and interpret trend results of information accumulated in development and
data within the product quality review during manufacturing
– To interpret monitoring data (e.g., to support an – To evaluate the impact of the changes on the
assessment of the appropriateness of revalidation availability of the final product
or changes in sampling)
Risk Mgmt as part of Integrated Quality Mgmt Risk Mgmt as part of Integrated Quality Mgmt
(FDA Q9) (FDA Q9)
Change management/Change control Continual improvement
– To evaluate the impact on product quality of – To facilitate continual improvement in processes
changes to the facility, equipment, material, throughout the product lifecycle
manufacturing process, or technical transfers
Other areas covered in FDA Q9:
– To determine appropriate actions preceding the
implementation of a change, e.g., additional testing, – Regulatory Operations
re-qualification, re-validation, or communication – Development
with regulators – Facilities, Equipment and Utilities
– Materials Management
– Production
– Packaging and Labeling
+/- 2 sigma
10 Operations
69.13 308,700
X
P
Machine - Equipment
y = f(x) 10 Orders per Year
S Prior Op s
+/- 5 sigma
10 Transactions per Unit per Operation
99.97670
= 233
(x) Method - Process +/- 6 sigma (near
6,000,000 Transactions per year
99.9997 3.4
perfect) (top companies)
Mater ials
Materials
Output
Man
Normal Abnormal
Necessary Unnecessary